-
Listing
Connecting Europe's Fixed Income MarketsOne connected fixed income ecosystem更多Seamless listing, trading, clearing and settlement for fixed income
-
Trading
Connecting Europe's Fixed Income MarketsOne connected fixed income ecosystem更多
Seamless listing, trading, clearing and settlement for fixed income
-
Clearing
Connecting Europe's Fixed Income MarketsOne connected fixed income ecosystem更多
Seamless listing, trading, clearing and settlement for fixed income
-
CSD
European CSD modelBuilding the CSD of Choice in Europe更多Euronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)更多The new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperNext generation of indices更多This white paper marks the second edition of Euronext’s Index Outlook series, a recurring publication designed to give investors deeper insight into our index innovation agenda and the structural forces shaping global markets.
-
About Euronext
Kiadis Pharma
04/06/2018
Kiadis Pharma sounds the gong in Amsterdam
Kiadis Pharma (ticker symbol: KDS), received this year’s tech 40 label from Euronext. Companies with the Tech 40 label are young technology companies listed on Euronext markets and operating in life sciences, eco-industries or TMT. An independent group of European experts selected the first 40 on the basis of their business, financial and stock market performance.
Kiadis Pharma is a clinical stage biopharmaceutical company focused on research, development and future commercialisation of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders.
For more information: www.kiadis.com